How to Avoid an ACO Exodus — or Having No Takers in the First Place
January 25th 2022Authors of an article in Health Affairs about a program for smaller and rural ACOs say their finding show those kinds of ACOs can generate major savings for Medicare, but apprehension about downside risk prompted an exodus from the program.
Read More
Erasing Bias in Clinical Decision Support to Achieve True Health Equity
January 21st 2022Many have claimed that technology will be the great equalizer in healthcare. While technology is objective and purely data-driven and without prejudice, there can still be inherent biases that hamper the ultimate goal of health equity.
Read More
COVID-19 and HIV: What Happens When Two Infectious Diseases Meet?
January 20th 2022Many of the darkest fears about COVID-19 affect on people with HIV have not come to pass. According to a recent review, some evidence suggests that people with HIV may be more likely to develop a severe case of COVID-19, although it isn’t certain. Antiretroviral therapy, especially Truvada, may provide some protection against infection and severity.
Read More
Five Tips to Help Block Blue Light in an Increasingly Remote World
January 16th 2022The use of digital devices has surged significantly as people spend more time at home, with Americans logging an average of 13 hours per day watching screens. That compares to between seven and 10 hours per day before the COVID-19 pandemic started, with the increase in screen time likely contributing to more exposure to blue light.
Read More
Researchers: Ancillary Services Would Comprise 20% of Medicare Spending on Aduhelm
January 15th 2022In a research letter published in JAMA Health Forum, researchers say most of the cost figures for Aduhelm have left out the additional MRI scans and other services that will be required because the drug is associated with the development of amyloid-related imaging abnormalities (ARIAs).
Read More
In First 2022 Recall, Metformin Pulled Back Because of Carcinogenic NDMA
January 14th 2022Problems with N-nitrosodimethylamine (NDMA)-contaminated metformin were identified by the FDA in 2020. Viona Pharmaceuticals announced in earlier this month that it was recalling 23 lots of the popular diabetes medication.
Read More